HOME Top Market Reports Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

By: marketsandmarkets.com
Publishing Date: April 2013
Report Code: BT 1862

Discount on Reports  

Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


The injectable drug delivery market is technology driven and is marked by “Threat of Obsolescence” wherein technologies as well as its adoption by patients changes very rapidly.
The industry has seen a shift in paradigm and is now skewed toward self-injection devices that not only cures serious illnesses, but also have fewer serious side effects. The market for injectable drug delivery includes devices and formulations. Traditionally, injectable devices were primarily designed for delivery of insulin and human growth hormones. However, due to technological advancements they are currently being used as combination therapies for the delivery of a wide variety of drug classes such as anticholinergic, hematopoietic, dopamine agonists, parathyroid hormones, reproductive hormones, serotonin antagonists, sympathomimetic and immune modulators.

Self injection devices including auto injectors and pen injectors are the fastest growing segments in the injectable drug delivery market. In recent years, the uptake and adoption of self-injection devices such as auto and pen injectors has grown substantially. This is due to the benefits it offers over conventional injection devices. Self-injection devices ensure better patient adherence to treatment due to decrease risk of missed injection or drug discontinuation, and reduced healthcare cost as costly hospital visits are curtailed. This has ignited the interest of device manufacturers who are in turn incessantly coming up with new variants of self-injection devices with advanced technological features.

Triggered by the upsurge of biologics and injectable drugs, pharmaceutical companies are increasingly adopting and venturing into self injection and microneedles injectable drug delivery technologies. These investments are likely to fortify global foot print of injectable manufacturers, helping them to extend their term of exclusivity for patented drugs with added therapeutic benefits, and to bring up new innovations in injectable devices segment. For instance, in February 2013, SHL Group expanded its auto injector facility in Taiwan with the investment of ~$40 million. The expansion increases the manufacturing capabilities of auto injectors for the firm. Similarly, in January 2012, Clearside Biomedical (an Atlanta-based start up) received $4 million from Hatteras Venture Partners (a venture capital firm in the U.S.) for the development of microinjection technology.

In the coming years, growth of injectable drug delivery market is likely to be hinged at China, India, Brazil, and Mexico. These countries offer an array of opportunities for growth and are likely to serve as revenue pockets for injectable drug delivery technologies market. All these countries offer high growth potential as compared to mature countries such as U.S. and Canada. Growth in these markets is spurred by the growing incidence of diabetes and cancer as the population ages. According to the International Diabetes Federation (IDF), diabetes affects ~285 million people globally, and this number is expected to reach 438 million by 2030, with two-thirds of all diabetes cases in low- to middle-income countries. In addition, British medical journal Lancet states that Asia's cancer rate is projected to reach the figure of 7.1 million new cases by 2020 (an increase of almost 60% compared to 2005). Thus, to meet the increasing demand of injectables for the treatment of chronic diseases in emerging markets, manufacturers are strategically focusing on new product launches, agreements and partnerships, resorting to geographical expansion to increase their market share. Regulatory policies in the Asia-Pacific region are more adaptive and business friendly due to less stringent regulations and less extensive data requirement. Increasing competition in mature markets will further trigger injectable drug delivery technologies manufacturers to focus on emerging markets.

Sustainability of players in highly competitive market is the key challenge that is expected to hinder the growth of the injectable drug delivery market. Injectable drug delivery technologies market is a highly diversified and competitive market with large number of market players including mid-tier firms and start-ups. Players operating in the market strive hard to gain market visibility and a larger market share. Due to high manufacturing cost, marketing and regulatory hurdles for approval of devices, companies struggle to survive and keep pace with the industry’s growth. As a result, companies focus on mergers and acquisitions to maintain their sustainability in the market.

The report extensively covers injectable drug delivery market for all major therapeutic areas- both qualitative (technological) and quantitative (revenue) aspects are analyzed at granular level. However, sub-segmentation of the therapeutic market by product type has not been provided as an injection device/formulation technology can be used for various therapeutic indications depending upon the need of the patient. Volume analysis of market has not been provided due to wide variation in prices of devices that varies with different therapeutic indications.

CUSTOMIZATION

Title: Pipeline Analysis for Dermal Injectables

Client:  U.S. based

Client noticed that the research and development activities have been picking up in the recent years and was interested to investigate the pipeline for dermal injectable molecules. In order to understand the upcoming market potential for various dermal injectables, client wanted to assess investigational dermal injectables on the basis of clinical trial phases, key players, research institutes, and their therapeutic applications. 

CONSULT

Title: Market Potential Evaluation for Hemodialysis Bloodline Set Components in India, China, and Brazil

Client: An Israel based global producer of disposable medical devices for OEM market

Client Objective: Client wanted to understand market overview of Brazil, India and China for components and final products (sets) in the hemodialysis bloodline sets. The study covered the following aspects of the hemodialysis bloodline sets market:

  • Value and Volume market for components and final products (sets) in desired countries
  • Factors impacting demand and supply
  • Market Dynamics –Major drivers, trends, restraints and opportunities which will have long term and short term impact on growth
  • Overview of Regulatory Environment and Purchasing Process
  • Prospective customers for the client in the desired markets

CONSULT

Title: Global Pen Needles Market in North America, Europe, and Asia (With focus on China)

Client: A Denmark based global leader in Diabetes Care

Client Objective: The firm is a major player within drug delivery devices and technologies especially pen needles. Client intends to explore the pen needle market in terms of market size and the growth forecast in the future. The study includes the following aspects of pen needle market:

  • To identify and estimate the market size for pen needle market segmented by geographies and product type by volume and value (in US dollars)
  • To infer and estimate the market size by needle size and product type
  • To identify and analyze the competition in pen needles market in a comprehensive manner
  • To identify and infer, the drivers, restraints, opportunities and challenges for the pen needles market
  • To identify and analyze, the ecosystem of pen needles market in the respective geographies

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauze the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping market share.

The report provides insights on the following pointers:

  • Comprehensive information on product portfolio and services offered by the top 20 players in the injectable drug delivery market. The report analyzes the injectable devices and formulations market by category/therapeutic areas across geographies –  Market Penetration


  • Detailed insights on upcoming technology, research and developments activities, and new product launches in the injectable drug delivery market – Product Development/Innovation


  • Comprehensive information about lucrative emerging markets. The report analyzes the promising injectable devices and formulations market by category/therapeutic areas across geographies– Market Development


  • Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the injectable drug delivery market – Market Diversification


  • In depth assessment of market share, strategies, products & services, distribution network, manufacturing capabilities of leading players in the injectable drug delivery market –Competitive Assessment

Customer Interested in this report also can view

  • North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

  • European Injectable Drug Delivery Market - Forecasts to 2017 By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017

Table Of Contents

1 Introduction (Page No. - 27)
  1.1 Key Take-Aways
  1.2 Report Description
  1.3 Markets Covered
  1.4 Stakeholders
  1.5 Research Methodology
      1.5.1 Market Size
      1.5.2 Market Share
      1.5.3 Key Data Points From Secondary Sources
      1.5.4 Key Data Points From Primary Sources
      1.5.5 Assumptions

2 Executive Summary (Page No. - 35)

3 Market Overview (Page No. - 40)
  3.1 Introduction
  3.2 Market Segmentation
  3.3 Market Dynamics
      3.3.1 Drivers
            3.3.1.1 Technological Advancements
            3.3.1.2 Product Life Cycle Management
            3.3.1.3 Surge Of Biologics In Pharmaceutical Markets
            3.3.1.4 Rising Incidences Of Cancer And Diabetes
            3.3.1.5 Improving Patient Compliance
      3.3.2 Restraints
            3.3.2.1 Regulatory Hurdles
            3.3.2.2 Needle-Stick Injuries And Infections
            3.3.2.3 Development Of Alternate Delivery Methods
            3.3.2.4 Product Recalls
      3.3.3 Opportunities
            3.3.3.1 Emerging Markets (India, China, Brazil, Mexico And Latin America)
            3.3.3.2 Development Of Biosimilars In The Pharmaceutical Market
      3.3.4 Challenges
            3.3.4.1 Sustainability Of Players In Highly Competitive Market
  3.4 Market Share Analysis, By Major Players
      3.4.1 Conventional Injectable Devices
      3.4.2 Self-Injection Devices
            3.4.2.1 Needle Free Injectors
            3.4.2.2 Auto Injectors
            3.4.2.3 Pen Injectors

4 Global Injectable Drug Delivery Devices Technologies Market (Page No. - 68)
  4.1 Introduction
  4.2 Market Segmentation
  4.3 Manufacturers Criteria For Selection Of An Injectable Device
  4.4 Conventional Injectable Drug Delvery Devices
      4.4.1 By Usability
            4.4.1.1 Disposable
            4.4.1.2 Reusable
      4.4.2 By Material
            4.4.2.1 Glass
            4.4.2.2 Plastic
      4.4.3 By Product
            4.4.3.1 Prefilled
            4.4.3.2 Fillable
  4.5 Self-Injection Devices
      4.5.1 Market Segmentation
      4.5.2 Selection Criteria For Self-Injection Device
      4.5.3 Pen Injectors
            4.5.3.1 By Product
                    4.5.3.1.1 Single Chamber Pen Injectors
                    4.5.3.1.2 Dual Chamber Pen Injectors
            4.5.3.2 By Usability
                    4.5.3.2.1 Disposable Pen Injectors
                    4.5.3.2.2 Reusable Pen Injectors
            4.5.3.3 By Design
                    4.5.3.3.1 Standard Pen Injectors
                    4.5.3.3.2 Customized Pen Injectors
      4.5.4 Needle-Free Injectors
            4.5.4.1 By Product
                    4.5.4.1.1 Prefilled Needle Free Injectors
                    4.5.4.1.2 Fillable Needle Free Injectors
            4.5.4.2 By Technology
                    4.5.4.2.1 Jet-Based Needle-Free Injectors
                    4.5.4.2.2 Spring-Based Needle-Free Injectors
                    4.5.4.2.3 Laser-Based Needle Free Injectors
                    4.5.4.2.4 Vibration-Based Needle Free Injectors
            4.5.4.3 By Usability
                    4.5.4.3.1 Disposable
                    4.5.4.3.2 Reusable
      4.5.5 Auto Injectors
            4.5.5.1 By Product
                    4.5.5.1.1 Prefilled Auto Injectors
                    4.5.5.1.2 Fillable Auto Injectors
            4.5.5.2 By Technology
                    4.5.5.2.1 Automated Auto Injectors
                    4.5.5.2.2 Manual Auto Injectors
            4.5.5.3 By Design
                    4.5.5.3.1 Standardized Auto Injectors
                    4.5.5.3.2 Customized Auto Injectors
            4.5.5.4 By Usability
                    4.5.5.4.1 Disposable Auto Injectors
                    4.5.5.4.2 Reusable Auto Injectors
  4.6 Others

5 Global Injectable Drug Delivery Formulation Technologies Market (Page No. - 140)
  5.1 Introduction
  5.2 Conventional Drug Delivery
      5.2.1 Injectable Solutions
      5.2.2 Reconstituted/Lyophilized Formulations
  5.3 Novel Drug Delivery Formulation Technologies
      5.3.1 Market Segmentation
      5.3.2 Liposomal Systems
      5.3.3 Microspheres
      5.3.4 Nanoparticles
      5.3.5 Polymeric Micelles
      5.3.6 Others

6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications (Page No. - 163)
  6.1 Introduction
  6.2 Auto-Immune Diseases
      6.2.1 Multiple Sclerosis
      6.2.2 Rheumatoid Arthritis
      6.2.3 Crohn's Diseases
      6.2.4 Psoriasis
      6.2.5 Others
  6.3 Hormonal Disorders
      6.3.1 Diabetes
      6.3.2 Anemia
      6.3.3 Reproductive Health Diseases
      6.3.4 Antithrombotic/Thrombolytic Therapy
      6.3.5 Osteoporosis
      6.3.6 Growth Hormone Deficiency
  6.4 Orphan/Rare Diseases
  6.5 Oncology
  6.6 Others
      6.6.1 Pain Management
      6.6.2 Hepatitis C
      6.6.3 Allergies
      6.6.4 Aesthetic Treatment

7 Geographic Analysis (Page No. - 206)
  7.1 Introduction
      7.1.1 North America Dominates The Market
  7.2 North America
      7.2.1 Growing Incidences Of Diabetes And Developments In Needle Free Technology Drive The Market
      7.2.2 Needlestick Injuries Have Been Hindering This Market
  7.3 Europe
      7.3.1 Liberalization Of Generics Market And Surge In Biologic Has Been Driving The Market
      7.3.2 High Presence Of Injectable Drug Delivery Market Leaders Drives The Market
      7.3.3 Hormonal Disorders Have Been Highly Affecting The Demographics In Europe
      7.3.4 The Region Has Strict Legislations To Prevent Rising Incidences Of Needlestick Injuries
  7.4 Asia-Pacific
      7.4.1 Apac Is The Fastest Growing Region For This Market
      7.4.2 The Region Experiences Rising Focus Of Various Giant Players
  7.5 Row
      7.5.1 Rising Incidences Of Cancer And Diabetes As Well As Adaptive Regulatory Policies Is Driving The Market
      7.5.2 Adaptive Regulatory Policies In Mexico & Brazil Is Supporting The Market Growth

8 Competitive Landscape (Page No. - 229)
  8.1 Introduction
  8.2 Expansion
  8.3 Agreements, Partnerships, Collaborations & Joint Ventures
  8.4 New Product Launch
  8.5 Mergers & Acquisitions
  8.6 Other Developments
  8.7 Approvals258

9 Company Profiles (Page No. - 260)
(Overview, Financials, Products & Services, Strategy, & Developments)*
  9.1 Alkermes, Inc.
  9.2 Antares Pharma, Inc.
  9.3 Baxter International, Inc.
  9.4 Becton, Dickinson And Company
  9.5 Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc)
  9.6 Crossject
  9.7 Elcam Medical
  9.8 Eli Lilly And Company
  9.9 Gerresheimer Ag
  9.10 Haselmeier Gmbh
  9.11 Injex Pharma Gmbh (Subsidiary Of Hns International, Inc.)
  9.12 Novo Nordisk A/S
  9.13 Owen Mumford, Ltd.
  9.14 Sanofi
  9.15 Schott Ag
  9.16 Shl Group
  9.17 Terumo Corporation
  9.18 Unilife Corporation
  9.19 Vetter Pharma-Fertigung Gmbh & Co. Kg
  9.20 West Pharmaceutical Services, Inc.
  9.21 Ypsomed Holding Ag
  9.22 Zogenix, Inc.
  *Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.
 

List Of Tables (155 Tables)

Table 1 Global Injection Drug Delivery Technologies Market,By Segment, 2010 – 2017 ($Billion)
Table 2 Global Injectable Drug Delivery Technologies Market,By Segment, 2010 – 2017 ($Billion)
Table 3 Injection Drug Delivery Technologies Market, By Geography, 2010 – 2017 ($Billion)
Table 4 Global Injectable Drug Delivery Devices Technologies Market, By Product, 2010 – 2017 ($Billion)
Table 5 Injection Drug Delivery Devices Technologies Market,By Geography, 2010 – 2017 ($Billion)
Table 6 Conventional Injection Devices Market, By Geography,2010 – 2017 ($Billion)
Table 7 Global Conventional Injection Devices Market, By Usability, 2010 – 2017 ($Billion)
Table 8 Disposable Conventional Devices Market, By Geography,2010 – 2017 ($Billion)
Table 9 Reusable Conventional Devices Market, By Geography,2010 – 2017 ($Billion)
Table 10 Global Conventional Injection Devices Market, By Material, 2010 – 2017 ($Billion)
Table 11 Conventional Injection Devices (Glass) Market,By Geography, 2010 – 2017 ($Billion)
Table 12 Conventional Injection Devices (Plastic) Market,By Geography, 2010 – 2017 ($Billion)
Table 13 Global Conventional Injection Devices Market, By Product, 2010 – 2017 ($Billion)
Table 14 Prefilled Conventional Injection Devices Market,By Geography, 2010 – 2017 ($Billion)
Table 15 Fillable Conventional Injection Devices Market,By Geography, 2010 – 2017 ($Billion)
Table 16 Major Therapeutic Areas For Self-Injection Devices
Table 17 Global Self-Injection Devices Market, By Product,2010 – 2017 ($Billion)
Table 18 Self-Injection Devices Market, By Geography,2010 – 2017 ($Billion)
Table 19 Pen Injector Market, By Geography, 2010 – 2017 ($Million)
Table 20 Global Pen Injectors Market, By Product,2010 – 2017 ($Million)
Table 21 Single Chamber Pen Injector Market, By Geography,2010 – 2017 ($Million)
Table 22 Dual Chamber Pen Injector Market, By Geography,2010 – 2017 ($Million)
Table 23 Global Pen Injectors Market, By Usability,2010 – 2017 ($Million)
Table 24 Disposable Pen Injectors Market, By Geography,2010 – 2017 ($Million)
Table 25 Reusable Pen Injectors Market, By Geography,2010 – 2017 ($Million)
Table 26 Global Pen Injectors Market, By Design,2010 – 2017 ($Million)
Table 27 Standard Pen Injectors Market, By Geography,2010 – 2017 ($Million)
Table 28 Customized Pen Injectors Market, By Geography,2010 – 2017 ($Million)
Table 29 Needle Free Injectors Market, By Geography,2010 – 2017 ($Million)
Table 30 Global Needle Free Injectors Market, By Product,2010 – 2017 ($Million)
Table 31 Prefilled Needle Free Injectors Market, By Geography,2010 – 2017 ($Million)
Table 32 Fillable Needle Free Injectors Market, By Geography,2010 – 2017 ($Million)
Table 33 Global Needle Free Injectors Market, By Technology,2010 – 2017 ($Million)
Table 34 Jet-Based Needle Free Injector Market, By Geography,2010 – 2017 ($Million)
Table 35 Spring-Based Needle Free Injector Market, By Geography, 2010 – 2017 ($Million)
Table 36 Laser-Powered Needle Free Injector Market, By Geography, 2010 – 2017 ($Million)
Table 37 Vibration-Based Needle Free Injector Market, By Geography, 2010 – 2017 ($Million)
Table 38 Global Needle Free Injectors Market, By Usability,2010 – 2017 ($Million)
Table 39 Disposable Needle Free Injectors Market, By Geography,2010 – 2017 ($Million)
Table 40 Reusable Needle Free Injectors Market, By Geography,2010 – 2017 ($Million)
Table 41 Auto Injectors Products Market, By Geography,2010 – 2017 ($Million)
Table 42 Global Auto Injectors Market, By Product,2010 – 2017 ($Million)
Table 43 Prefilled Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 44 Fillable Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 45 Global Auto Injectors Market, By Technology,2010 – 2017 ($Million)
Table 46 Automated Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 47 Manual Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 48 Global Auto Injectors Market, By Design,2010 – 2017 ($Million)
Table 49 Standardized Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 50 Customized Auto Injectors Auto Injectors Market,By Geography, 2010 – 2017 ($Million)
Table 51 Global Auto Injectors Market, By Usability,2010 – 2017 ($Million)
Table 52 Disposable Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 53 Reusable Auto Injectors Market, By Geography,2010 – 2017 ($Million)
Table 54 Others Injectors Market, By Geography,2010 – 2017 ($Million)
Table 55 Global Injectable Drug Delivery Formulation Technologies Market, By Segment, 2010 – 2017 ($Billion)
Table 56 Injectable Drug Delivery Formulation Technologies Market, By Geography, 2010 – 2017 ($Billion)
Table 57 Global Conventional Drug Delivery Formulation Technologies Market, 2010 – 2017 ($Billion)
Table 58 Conventional Drug Delivery Formulation Technologies Market, By Geography, 2010 – 2017 ($Billion)
Table 59 Injectable Solutions Conventional Drug Delivery Formulation Market, By Geography, 2010 – 2017 ($Billion)
Table 60 Reconstituted/Lyophilized Conventional Drug Delivery Formulation Market, By Geography, 2010 – 2017 ($Billion)
Table 61 Novel Drug Delivery Formulation Technologies Market,2010 – 2017 ($Billion)
Table 62 Novel Drug Delivery Formulation Technologies Market,By Geography, 2010 – 2017 ($Billion)
Table 63 Liposome Drug Delivey Formulation Market, By Geography, 2010 – 2017 ($Million)
Table 64 Microspheres Drug Delivey Formulation Market,By Geography, 2010 – 2017 ($Million)
Table 65 Nanoparticles Drug Delivey Formulation Market,By Geography, 2010 – 2017 ($Million)
Table 66 Polymeric Micelles Drug Delivey Formulation Market,By Geography, 2010 – 2017 ($Million)
Table 67 Others Novel Drug Delivey Formulation Market,By Geography, 2010 – 2017 ($Billion)
Table 68 Global Injectable Drug Delivery Technologies Market,By Therapeutic Applications, 2010 – 2017 ($Million)
Table 69 Global Auto-Immune Therapeutic Market, By Indication,2010 – 2017 ($Million)
Table 70 Auto-Immune Therapeutic Market, By Geography,2010 – 2017 ($Million)
Table 71 Multiple Sclerosis Market, By Geography,2010 – 2017 ($Million)
Table 72 Rheumatoid Arthritis Market, By Geography,2010 – 2017 ($Million)
Table 73 Crohn's Diseases Market, By Geography,2010 – 2017 ($Million)
Table 74 Psoriasis Market, By Geography, 2010 – 2017 ($Million)
Table 75 Other Auto-Immune Diseases Market, By Geography,2010 – 2017 ($Million)
Table 76 Global Hormonal Disorders, By Indication,2010 – 2017 ($Million)
Table 77 Hormonal Disorders Market, By Geography,2010 – 2017($Billion)
Table 78 Diabetes Market, By Geography, 2010 – 2017 ($Billion)
Table 79 Anemia Market, By Geography, 2010 – 2017 ($Million)
Table 80 Reproductive Health Diseases Market, By Geography,2010 – 2017($Million)
Table 81 Antithrombotic Therapy Market, By Geography,2010 – 2017 ($Million)
Table 82 Osteoporosis Market, By Geography, 2010 – 2017($Million)
Table 83 Growth Hormone Deficiency Market, By Geography,2010 – 2017 ($Million)
Table 84 Orphan/Rare Diseases Therapeutic Market, By Geography, 2010 – 2017 ($Million)
Table 85 Oncology Therapeutic Market, By Geography,2010 – 2017 ($Million)
Table 86 Global Other Therapeutic Market, 2010 – 2017 ($Million)
Table 87 Other Therapeutic Market, By Geography,2010 – 2017 ($Million)
Table 88 Pain Management Market, By Geography, 2010 – 2017 ($Million)
Table 89 Hepatitis C Market, By Geography, 2010 – 2017 ($Million)
Table 90 Allergies/Anaphylytic Shock Market, By Geography,2010 – 2017 ($Million)
Table 91 Aesthetic Treatment Market, By Geography,2010 – 2017 ($Million)
Table 92 North America: Injectable Drug Delivery Technologies Market,2010 – 2017 ($Billion)
Table 93 North America: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 – 2017 ($Billion)
Table 94 North America: Injectable Drug Delivery Formulation Technologies Market, 2010 – 2017 ($Billion)213
Table 95 North America: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 – 2017 ($Billion)
Table 96 Europe: Injectable Drug Delivery Technologies Market,2010 – 2017 ($Billion)
Table 97 Europe: Injectable Drug Delivery Devices Technologies Market, 2010 – 2017 ($Million)
Table 98 Europe Injectable Drug Delivery Formulations Technologies Market, By Segment, 2010 – 2017 ($Billion)
Table 99 Europe: Injectable Drug Delivery Technologies Market,By Therapeutic Appliction, 2010 – 2017 ($Billion)
Table 100 Apac: Injectable Drug Delivery Technologies Market,By Segment,2010 – 2017 ($Billion)
Table 101 Apac: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 – 2017 ($Million)
Table 102 Apac: Injectable Drug Delivery Formulations Technologies Market, By Segment, 2010 – 2017 ($Billion)
Table 103 Apac: Injectable Drug Delivery Technologies Market,By Therapeutic Application, 2010 – 2017 ($Million)
Table 104 Row: Injectable Drug Delivery Technologies Market,By Segment, 2010 – 2017 ($Million)
Table 105 Row: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 – 2017 ($Million)
Table 106 Row: Injectable Drug Delivery Formulations Technologies Market, By Segment, 2010 – 2017 ($Million)
Table 107 Row: Injectable Drug Delivery Technologies Market,By Therapeutic Application, 2010 – 2017 ($Million)
Table 108 Expansion, 2010 – 2013
Table 109 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 – 2013
Table 110 New Product Launch, 2010 – 2013
Table 111 Mergers & Acquisitions, 2010 – 2013
Table 112 Other Developments, 2010 – 2013
Table 113 Approvals, 2010 – 2013
Table 114 Alkermes: Total Revenue And R&D Expenses,2009– 2011 ($Million)
Table 115 Alkermes: Total Revenue, By Geography, 2009 – 2011 ($Million)
Table 116 Antares Pharma: Total Revenues And R&D Expenditure,2010 – 2012 ($Million)
Table 117 Antares Pharma: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 118 Antares Pharma: Total Revenue, By Product,2010 – 2012 ($Million)
Table 119 Baxter International: Total Revenue And R&D Expenses,2010 – 2012 ($Million)
Table 120 Baxter International: Total Revenue, By Segment,2010 – 2012 ($Million)
Table 121 Baxter International: Medical Products Total Revenue,2010 – 2012($Million)
Table 122 Baxter International: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 123 Becton Dickinson: Total Revenues & R&D Expenditure,2010 – 2012 ($Million)
Table 124 Becton Dickinson: Total Revenue, By Segment,2010 – 2012 ($Million)
Table 125 Becton Dickinson: Medical Division Total Revenue,2010 – 2012 ($Million)
Table 126 Becton Dickinson: Total Revenue, By Geography,2010– 2012 ($Million)
Table 127 Consort Medical: Total Revenue And R&D Expense,2009 – 2011 ($Million)
Table 128 Consort Medical: Total Revenue, By Geography,2009 – 2011 ($Million)
Table 129 Eli Lilly & Co: Total Revenue And R&D Expenses,2010 – 2012 ($Billion)
Table 130 Eli Lilly & Co: Total Revenue, By Segment,2010 – 2012 ($Billion)
Table 131 Eli Lilly & Co: Total Revenue By Geography,2010 – 2012 ($Billion)
Table 132 Gerresheimer Ag: Total Revenue And R&D Expenses,2010 – 2012 ($Million)
Table 133 Gerresheimer Ag: Total Revenue, By Segment,2010 – 2012 ($Million)
Table 134 Gerresheimer Ag: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 135 Novo Nordisk: Total Revenue And R&D Expenses,2010 – 2012 ($Billion)
Table 136 Novo Nordisk: Total Revenue, By Segment,2010 – 2012 ($Billion)
Table 137 Novo Nordisk: Total Revenue, By Geography,2010 – 2012 ($Billion)
Table 138 Sanofi: Total Revenue & R&D Expenditure,2010 – 2012 ($Billion)
Table 139 Sanofi: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 140 Sanofi: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 141 Schott Ag: Total Revenue And R&D Expenditures,2010 – 2012 ($Million)
Table 142 Schott Ag: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 143 Terumo Corporation: Total Revenue And R&D Expenses,2009 – 2011 ($Million)
Table 144 Terumo Corporation: Total Revenue, By Segment,2009 – 2011 ($Million)
Table 145 Terumo Corporation: Total Revenue, By Geography,2009 – 2011 ($Million)
Table 146 Unilife Corporation: Total Revenue And Expenditure,2009 – 2011 ($Million)
Table 147 Unilife Corporation: Total Revenue-By Geography,2009 – 2011 ($Million)
Table 148 West Pharma: Total Revenues And R&D Expenses,2010 – 2012 ($Million)
Table 149 West Pharma: Total Revenue, By Segment,2010 – 2012 ($Million)
Table 150 West Pharma: Total Revenue, By Geography,2009 – 2012 ($Million)
Table 151 Ypsomed: Total Revenue And R&D Expenses,2009 – 2011 ($Million)
Table 152 Ypsomed: Total Revenue, By Segment, 2009 – 2011 ($Million)
Table 153 Ypsomed: Total Revenue, By Geography, 2009 ($Million)
Table 154 Ypsomed: Total Revenue, By Geography, 2010 – 2011 ($Million)
Table 155 Zogenix, Inc.: Total Revenue And R&D Expenditure,2010 – 2012 ($ Million)


List Of Figures (27 Figures)

Figure 1 Global Injectable Drug Delivery Technologies Market,By Segment, 2012 & 2017
Figure 2 Injectable Drug Delivery Technologies Market,By Geography, 2012
Figure 3 Injectable Drug Delivery Technologies Market Segmentation
Figure 4 Injectable Drug Delivery Technologies Market Segmentation
Figure 5 Market Segmentation Of Injectable Drug Delivery Technologies, By Therapeutic Application
Figure 6 Injectable Drug Delivery Technologies Market Dynamics
Figure 7 Global Conventional Injection Devices Market,By Key Players, 2012 ($Million)
Figure 8 Global Self-Injection Devices Market, By Key Players,2012 ($Million)
Figure 9 Global Needle Free Injector Market, By Key Players,2012 ($Million)
Figure 10 Global Auto Injector Market, By Key Players, 2012 ($Million)
Figure 11 Global Pen Injector Market, By Key Players, 2012 ($Million)
Figure 12 Injectable Drug Delivery Devices Technologies Market Segmentation
Figure 13 Factors Affecting Selection Of An Injectable Device
Figure 14 Global Self-Injection Devices Market, By Product,2010 – 2017 ($Billion)
Figure 15 Self-Injection Devices Market Segmentation
Figure 16 Factors Affecting Selection Of Self-Injection Device
Figure 17 Conventional Drug Delivery Formulation Technologies Market Segmentation
Figure 18 Global Novel Drug Delivey Formulation Market,2012 & 2017 ($Billion)
Figure 19 Novel Drug Delivery Formulation Technologies Segmentation
Figure 20 Global Injectable Drug Delivery Technologies Market,By Therapeutic Application, 2010 – 2017 ($Billion)
Figure 21 Injectable Drug Delivery Technologies Market Segmentation, By Therapeutic Applications
Figure 22 Auto-Immune Therapeutic Market Segmentation
Figure 23 Hormonal Disorders Market Segmentation
Figure 24 Injectable Drug Delivery Technologies Market,By Geography, 2012 – 2017 ($Billion)
Figure 25 Key Growth Strategies, 2010 – 2013
Figure 26 Key Players Focusing On Expansion, 2010 – 2013
Figure 27 Key Players Focusing On Agreements, Partnerships, Collaborations And Joint Ventures, 2010 – 2013

Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The injectable drug delivery formulation technologies segment accounted for the largest share of the overall injection drug delivery technologies market and is expected to at a CAGR of 16.3% from 2012 to 2017. This is due to surge of biologics and development of nanotechnologies. Based on product, the injectable drug delivery devices technologies market is further categorized into conventional injection devices, self injection devices, and others (microneedles, nanoneedles and blunt needle injections), while injectable drug delivery formulation technologies market is categorized into conventional drug delivery formulations and novel drug delivery formulations. Conventional injection devices segment accounted for the largest shareof the overall injectable drug delivery technologies market in 2012.

Furthermore, the market is segmented on the basis of its therapeutic applications such as auto immune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, and Wilson’s disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment). Hormonal disorders commanded the largest share of the global injectable drug delivery technologies market in 2012.

The global injectable drug delivery technologies market has witnessed challenging and dynamic market conditions (due to technological advancements and surge of biologics and biosimilars in pharmaceutical market) over the last five years. Newer products with better safety and efficacy contribute to the widespread adoption of injectable drug delivery technologiesby physicians and patients. However, factors such as regulatory hurdles, needle-stick injuries and infections, development of alternate delivery methods (oral, nasal and topical) for injectable drugs, and product recalls are restraining the growth of the market.

The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), SHL Group (Taiwan), Ypsomed Holding AG (Switzerland), Terumo Corporation (Japan) and Schott AG (Germany), Owen Mumford Ltd (U.K.), and Antares Pharma, Inc. (U.S.).

GLOBAL INJECTABLE DRUG DELIVERY TECHNOLOGIES MARKET,BY GEOGRAPHY, 2012 ($BILLION)

INJECTABLE DRUG DELIVERY TECHNOLOGIES MARKET

Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Expert Interviews, MnM Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports